- North America, Asia
- South Korea
- Biopharmaceuticals, Generics, …
- Service category
- Clinical development and testing, clinical CRO, Regulatory services - CMC writing - medical writing, …
Your company? Get access to this profile.
LSK Global PS is a CRO pursuing quality, quality only. From its birth in March 2000, LSK’s clinical studies and trials have strictly followed ICH-GCP guidelines so that the quality of trials conducted by LSK may meet international standards. All of its SOPs are in English.
LSK has a simple-minded goal: to bring the standards of Korean clinical trials up to the global level. LSK clinical trials are already competitive in the international community and of quality that meets regulatory requirements of the US and EU. A continued global acceptance of its clinical trials is LSK’s commitment
LSK is the first and only Korean CRO that has successfully conducted clinical trials of Korean pharmaceutical products outside Korea. LSK is also the only Korean CRO attracting multinational clinical trials on its own international connection and reputation.
Multinational pharmaceutical companies and CROs recognize LSK as a Global level CRO.
LSK’s capability has been upgraded through numerous audits by multinational CROs and pharmaceutical companies. We have not been audited by the US FDA yet.
LSK uses US GCP-compliant and authorized statistical and DM software.
You might also be interested in
Sourcing this company's services?Send inquiry anonymously »